APA (7th ed.) Citation

Gilleen, J., Farah, Y., Davison, C., Kerins, S., Valdearenas, L., Uz, T., . . . Shergill, S. S. (2021). An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients. Psychopharmacology, 238(5), 1279-1289. https://doi.org/10.1007/s00213-018-5134-y

Chicago Style (17th ed.) Citation

Gilleen, James, et al. "An Experimental Medicine Study of the Phosphodiesterase-4 Inhibitor, Roflumilast, on Working Memory-related Brain Activity and Episodic Memory in Schizophrenia Patients." Psychopharmacology 238, no. 5 (2021): 1279-1289. https://doi.org/10.1007/s00213-018-5134-y.

MLA (9th ed.) Citation

Gilleen, James, et al. "An Experimental Medicine Study of the Phosphodiesterase-4 Inhibitor, Roflumilast, on Working Memory-related Brain Activity and Episodic Memory in Schizophrenia Patients." Psychopharmacology, vol. 238, no. 5, 2021, pp. 1279-1289, https://doi.org/10.1007/s00213-018-5134-y.